tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TNYA Stock Latest News

Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
RatingsAdvancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
4d ago
TNYA
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
PremiumRatings
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
4d ago
TNYA
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
PremiumRatings
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
4d ago
TNYA
Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)
PremiumThe Fly
Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)
5d ago
TNYA
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
5d ago
EVAX
IMRX
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
PremiumRatingsTN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
7d ago
TNYA
Tenaya Therapeutics presents preclinical data evaluating TN-301
Premium
The Fly
Tenaya Therapeutics presents preclinical data evaluating TN-301
7d ago
TNYA
Tenaya Therapeutics: Alnylam Partnership Validates Cardiovascular Platform and Supports Long-Term Buy Thesis
Premium
Ratings
Tenaya Therapeutics: Alnylam Partnership Validates Cardiovascular Platform and Supports Long-Term Buy Thesis
11d ago
TNYA
Tenaya Therapeutics: Alnylam Collaboration De-Risks Platform and Expands Cardiovascular Upside, Supporting Buy Rating
PremiumRatings
Tenaya Therapeutics: Alnylam Collaboration De-Risks Platform and Expands Cardiovascular Upside, Supporting Buy Rating
11d ago
TNYA
Tenaya Therapeutics Announces Major Cardiovascular Gene Target Collaboration
PremiumCompany Announcements
Tenaya Therapeutics Announces Major Cardiovascular Gene Target Collaboration
11d ago
8K
TNYA
Tenaya Therapeutics enters research collaboration with Alnylam
PremiumThe Fly
Tenaya Therapeutics enters research collaboration with Alnylam
11d ago
ALNY
TNYA
e.l.f., Crown Castle, DoorDash, Stag, Tenaya Shake-Up
PremiumWeekend Updates
e.l.f., Crown Castle, DoorDash, Stag, Tenaya Shake-Up
16d ago
CCI
ELF
Tenaya Therapeutics Faces Nasdaq Deficiency, Amends Equity Plan
PremiumCompany AnnouncementsTenaya Therapeutics Faces Nasdaq Deficiency, Amends Equity Plan
1M ago
8K
TNYA
Tenaya Therapeutics: 2026 Clinical Milestones, FDA Pivotal Pathway, and Strengthened Balance Sheet Support Buy Rating
Premium
Ratings
Tenaya Therapeutics: 2026 Clinical Milestones, FDA Pivotal Pathway, and Strengthened Balance Sheet Support Buy Rating
2M ago
TNYA
Tenaya Therapeutics: 2026 as a Pivotal Year for TN-201 and TN-401 Clinical Readouts and Regulatory De-Risking Supporting a Buy Rating
Premium
Ratings
Tenaya Therapeutics: 2026 as a Pivotal Year for TN-201 and TN-401 Clinical Readouts and Regulatory De-Risking Supporting a Buy Rating
2M ago
TNYA
Tenaya Therapeutics announces 2026 strategic priorities
PremiumThe Fly
Tenaya Therapeutics announces 2026 strategic priorities
2M ago
TNYA
Tenaya Therapeutics price target lowered to $2 from $5 at Morgan Stanley
PremiumThe Fly
Tenaya Therapeutics price target lowered to $2 from $5 at Morgan Stanley
2M ago
TNYA
Tenaya Therapeutics announces orderly board leadership transition
PremiumCompany Announcements
Tenaya Therapeutics announces orderly board leadership transition
2M ago
8K
TNYA
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord
PremiumThe Fly
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord
3M ago
TNYA
Promising Initial Data and Safety Profile Justify Buy Rating for Tenaya Therapeutics’ TN-401
PremiumRatingsPromising Initial Data and Safety Profile Justify Buy Rating for Tenaya Therapeutics’ TN-401
3M ago
TNYA
Tenaya Therapeutics Announces Public Offering Pricing
Premium
Company Announcements
Tenaya Therapeutics Announces Public Offering Pricing
3M ago
8K
TNYA
Promising Clinical Developments and FDA Approval Boost Tenaya Therapeutics’ Buy Rating
Premium
Ratings
Promising Clinical Developments and FDA Approval Boost Tenaya Therapeutics’ Buy Rating
3M ago
TNYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >